Cipher Pharmaceuticals (STU:PHE) YoY EBITDA Growth : 20.63% (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Cipher Pharmaceuticals YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Cipher Pharmaceuticals's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 20.63%.

Cipher Pharmaceuticals's EBITDA per Share for the three months ended in Mar. 2025 was €0.15.

Cipher Pharmaceuticals YoY EBITDA Growth Historical Data

The historical data trend for Cipher Pharmaceuticals's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipher Pharmaceuticals YoY EBITDA Growth Chart

Cipher Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

-7.98

87.60

-2.86

-5.67

7.93

Cipher Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial															28.57	5.83	10.83	-31.63	20.63

Cipher Pharmaceuticals YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Cipher Pharmaceuticals's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(0.449	-	0.416)	/	\| 0.416 \|
=	7.93 %

Cipher Pharmaceuticals's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(0.152	-	0.126)	/	\| 0.126 \|
=	20.63 %

Cipher Pharmaceuticals YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Cipher Pharmaceuticals's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Cipher Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipher Pharmaceuticals Inc (STU:PHE) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

CPHRF:USA PHE:Germany CPH:Canada

Address

5750 Explorer Drive, Suite 404, Mississauga, ON, CAN, L4W 0A9

Website

https://www.cipherpharma.com

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company is building its business through product acquisitions, out-licensing and in-licensing arrangements. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.

Cipher Pharmaceuticals Headlines

No Headlines